Menu
Menu
Le invitamos a participar en el exclusivo GENOMICS INSIGHTS DAY, un encuentro que reunirá a expertos y líderes clínicos para explorar los avances más recientes en genómica aplicada, oncología y diagnóstico de enfermedades raras.
El evento contará con la participación de especialistas y clientes que compartirán su experiencia real en la práctica clínica, abordando temas de alto impacto: desde la implementación de paneles de cáncer hereditario hasta el uso del exoma clínico como solución multipanel para el diagnóstico genético de enfermedades raras. La jornada culminará con una visión integral presentada por nuestro equipo sobre el rastreo del cáncer: del riesgo hereditario a la detección en tempo real.
Asimismo, el evento destacará experiencias reales de clientes que compartirán su práctica clínica utilizando la plataforma SOPHiA DDM™, ofreciendo una perspectiva concreta sobre su impacto en el diagnóstico y la toma de decisiones.
A continuación, encontrará la agenda preliminar del evento
What: SOPHiA GENETICS Exclusive Networking event
Where: Hotel Ritz-Carlton
Date: 28 de mayo
Time: 19:00 - 22:00
19:00 – 19:30
De somático a germinal en cáncer: Implementación de un panel de cáncer hereditario.
Francisco Pérez Blanco, PhD,
Coordinador Diagnóstico Molecular y Biomarcadores en Clínica Alemana de Santiago, Chile
19:30 – 20:00
El Exoma Clínico: una solución multipanel.
Diagnóstico genético de enfermedades raras
Juan Martín Marques, PhD,
Líder de Servicios de NGS, Laboratorio de Biología Molecular del Sanatorio Americano , Uruguay
20:00 - 20:30
Rastreando el Cáncer: Del Riesgo Hereditario a la Detección en Tiempo Real
Bruno Piovezan Subject Matter Expert LATAM
SOPHiA GENETICS
21:00 – 22:00
Cocktails & Networking
Discover how SOPHiA DDM™ enables accurate analysis across multiple disease areas – from oncology to inherited disorders
Connect with your peers and Enjoy a networking environment with your peers and users of SOPHiA DDM™ Platform.
Discuss the future of research and healthcare institutions to harness NGS data for quick, robust, and actionable insights, guiding best decisions.
SOPHiA GENETICS products are for Research Use Only and not for use in diagnostic procedures unless specified otherwise.
SOPHiA DDM™ Dx Hereditary Cancer Solution, SOPHiA DDM™ Dx RNAtarget Oncology Solution and SOPHiA DDM™ Dx Homologous Recombination Deficiency Solution are available as CE-IVD products for In Vitro Diagnostic Use in the European Economic Area (EEA), the United Kingdom and Switzerland. SOPHiA DDM™ Dx Myeloid Solution and SOPHiA DDM™ Dx Solid Tumor Solution are available as CE-IVD products for In Vitro Diagnostic Use in the EEA, the United Kingdom, Switzerland, and Israel. Information about products that may or may not be available in different countries and if applicable, may or may not have received approval or market clearance by a governmental regulatory body for different indications for use. Please contact us to obtain the appropriate product information for your country of residence.
All third-party trademarks listed by SOPHiA GENETICS remain the property of their respective owners. Unless specifically identified as such, SOPHiA GENETICS’ use of third-party trademarks does not indicate any relationship, sponsorship, or endorsement between SOPHiA GENETICS and the owners of these trademarks. Any references by SOPHiA GENETICS to third-party trademarks is to identify the corresponding third-party goods and/or services and shall be considered nominative fair use under the trademark law.
